-
EP2078531
European procedure
Extract from the Register of European Patents
EP About this file: EP2078531
| EP2078531 - Pharmaceutical compositions and methods useful for modulating angiogenesis [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 05.04.2013 Database last updated on 11.04.2026 | Most recent event Tooltip | 05.04.2013 | No opposition filed within time limit | published on 08.05.2013 [2013/19] | Applicant(s) | For all designated states TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. Gutwhirth Science Park Technion City Haifa 32 000 / IL | [2009/29] | Inventor(s) | 01 /
Neufeld, Gera 23 Shoham Street 34 679 Haifa / IL | 02 /
Akiri, Gal 19 Bar Lev Street 32 884 Haifa / IL | 03 /
Vadasz, Zhava 20 Hesel Street 32 446 Haifa / IL | 04 /
Gengrovitch, Stela 17 Omer Street 21 960 Karmiel / IL | [2009/29] | Representative(s) | Schüssler, Andrea Kanzlei Huber & Schüssler Truderinger Strasse 246 81825 München / DE | [N/P] |
| Former [2012/22] | Schüssler, Andrea Patentanwälte Huber & Schüssler Truderinger Strasse 246 81825 München / DE | ||
| Former [2009/29] | Schüssler, Andrea Patentanwälte Huber & Schüssler, Truderinger Strasse 246 81825 München / DE | Application number, filing date | 08020754.1 | 07.08.2001 | [2009/29] | Priority number, date | US20000223739 | 08.08.2000 Original published format: US 223739 | [2009/29] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP2078531 | Date: | 15.07.2009 | Language: | EN | [2009/29] | Type: | A3 Search report | No.: | EP2078531 | Date: | 20.01.2010 | [2010/03] | Type: | B1 Patent specification | No.: | EP2078531 | Date: | 30.05.2012 | Language: | EN | [2012/22] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 21.12.2009 | Classification | IPC: | A61K39/395 | [2009/29] | CPC: |
C12Y104/03013 (EP);
A61P35/00 (EP);
C07K16/40 (EP);
C12N9/0022 (EP);
A61K38/00 (EP)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2010/40] |
| Former [2010/38] | AT, BE, CH, CY, DE, LI | ||
| Former [2009/29] | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR | Title | German: | Nützliche pharmazeutische Zusammensetzungen und Verfahren für Angiogenesemodulation | [2009/29] | English: | Pharmaceutical compositions and methods useful for modulating angiogenesis | [2009/29] | French: | Compositions pharmaceutiques et procédés utiles pour la modulation d'angiogénèse | [2009/29] | Examination procedure | 20.07.2010 | Amendment by applicant (claims and/or description) | 20.07.2010 | Examination requested [2010/35] | 22.10.2010 | Despatch of a communication from the examining division (Time limit: M04) | 09.02.2011 | Reply to a communication from the examining division | 15.03.2011 | Despatch of a communication from the examining division (Time limit: M04) | 20.07.2011 | Reply to a communication from the examining division | 25.11.2011 | Communication of intention to grant the patent | 30.03.2012 | Fee for grant paid | 30.03.2012 | Fee for publishing/printing paid | Parent application(s) Tooltip | EP01958338.4 / EP1315519 | Divisional application(s) | EP10012457.7 / EP2359853 | EP10012458.5 / EP2359854 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20010958338) is 14.11.2005 | Opposition(s) | 01.03.2013 | No opposition filed within time limit [2013/19] | Fees paid | Renewal fee | 12.12.2008 | Renewal fee patent year 03 | 12.12.2008 | Renewal fee patent year 04 | 12.12.2008 | Renewal fee patent year 05 | 12.12.2008 | Renewal fee patent year 06 | 12.12.2008 | Renewal fee patent year 07 | 12.12.2008 | Renewal fee patent year 08 | 25.08.2009 | Renewal fee patent year 09 | 17.08.2010 | Renewal fee patent year 10 | 11.08.2011 | Renewal fee patent year 11 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A] WO0044910 (MILLENNIUM PHARM INC et al.) [A] 1-5 * the whole document * | [T] WO2004047720 (TECHNION RES & DEV FOUNDATION et al.) [T] 1-5 * the whole document * | [E] WO0183702 (UNIV HAWAII et al.) [E] 1-5 * the whole document * | [A] SAITO H ET AL: "Regulation of a novel gene encoding a lysyl oxidase-related protein in cellular adhesion and senescence", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM, US, vol. 272, no. 13, 28 March 1997 (1997-03-28), pages 8157 - 8160, XP002187526, ISSN: 0021-9258 [A] 1-5 * the whole document * DOI: http://dx.doi.org/10.1074/jbc.272.13.8157 | [PA] ITO HIROMU ET AL: "Molecular cloning and biological activity of a novel lysyl oxidase-related gene expressed in cartilage", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM, US, vol. 276, no. 26, 29 June 2001 (2001-06-29), pages 24023 - 24029, XP002199860, ISSN: 0021-9258 [PA] 1-5 * the whole document * DOI: http://dx.doi.org/10.1074/jbc.M100861200 | [L] AKIRI GAL ET AL: "Lysyl oxidase-related protein-1 promotes tumor fibrosis and tumor progression in vivo", 20030401, vol. 63, no. 7, 1 April 2003 (2003-04-01), pages 1657 - 1666, XP002336330 [L] 1-5 * the whole document * | [L] PEINADO H ET AL: "A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression", EMBO JOURNAL, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 24, no. 19, 5 October 2005 (2005-10-05), pages 3446 - 3458, XP008091358, ISSN: 0261-4189 [L] 1-5 * the whole document * DOI: http://dx.doi.org/10.1038/sj.emboj.7600781 | Examination | VAN BERGEN ET AL: "The role of LOXa nd LOXL2 in wound healing after glaucoma filtration surgery", 8 October 2010 (2010-10-08), Retrieved from the Internet |